Please Wait...

End-to-End Patient Engagement Is a Reality

Patient engagement is an ongoing challenge when conducting clinical trials. A recent article published in CenterWatch Weekly noted, "Experts point to problems with awareness, understanding, and trust among potential trial participants as well as providers that persists today. They also cite the disconnect between a patient's interest in participating in a trial and actually taking the next step to enroll. Other challenges include difficulty in enrolling more diverse populations, recruiting specific patient types for targeted studies, and the costly fact that up to 10 percent of enrollees are lost to follow-up."

Bioclinica is addressing the challenge of patient engagement head on with the creation of two new divisions within their Global Clinical Research area: a Research Network and a Patient Recruitment division. Together, the two divisions will support end-to-end patient engagement. John Hubbard, Ph.D., president and CEO of Bioclinica, stated, "Our view is that by combining these two modalities, we could accelerate and enhance the ability to enroll and retain patients. We've combined best-in-class approaches in recruitment with using our centers as a vehicle to bring patients in."

To read more about how Bioclinica is supporting patient engagement through the use of technology, targeted recruitment strategies, and a patient-centric approach, read the full article here.

Category: 

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing w Quality & Consistency While Crossing One Mil… https://t.co/77NOME2Dj7
bioclinica (Yesterday)
Who made the BioSpace list of 11 most innovative life sciences companies in the world? Ck it out here via @biospace… https://t.co/f9vtRpsbMW
bioclinica (Yesterday)
BREAKING: With a passion for Drug Safety, we’re delighted to share @bioclinica #pharmacovigilance crossed 1M ICSR c… https://t.co/PAdROjo7tE
bioclinica (2 days ago)
RT @isciencebox: Draft and Final FDA Guidances Detail Development of New Drugs for Neurological Disorders @RAPSorg https://t.co/cAewLypUY7
bioclinica (2 days ago)
RT @RAPSorg: Final @US_FDA Rule Requires Medical Device Trials Outside US to Conform to GCP | #Regulatory Focus https://t.co/jgwaqxfiXl #FD…
bioclinica (2 days ago)
Congrats @bioclinica on @Clin_Info_News Best Practices Award 4 "Transformational Med. Imaging in #ClinicalTrials. '… https://t.co/NxauNywq23
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen